What is Colorescience?
Headquartered in Carlsbad, California, Colorescience operates at the intersection of dermatology and high-end cosmetics. The company distinguishes itself through a clinically validated product line that is widely endorsed by dermatologists, plastic surgeons, and medical spas. By leveraging a sophisticated omni-channel distribution strategy—spanning professional medical channels, direct-to-consumer platforms, and strategic e-commerce partnerships—Colorescience has effectively captured a significant share of the premium skincare market. Its focus on daily-use sun protection and innovative skin-strengthening formulations positions it as a leader in the intersection of health and beauty, catering to a demographic that prioritizes both efficacy and aesthetic elegance.
How much funding has Colorescience raised?
Colorescience has raised a total of $87.6M across 9 funding rounds:
Series A
$10M
Series B
$15M
Debt
$4M
Other Financing Round
$6.5M
Private Equity
$4.2M
Series C
$15M
Debt
$1M
Debt
$30M
Debt
$1.9M
Series A (2013): $10M with participation from Montreux Equity Partners. and Split Rock Partners
Series B (2014): $15M led by Longwood Fund
Debt (2016): $4M, investors not publicly disclosed
Other Financing Round (2016): $6.5M featuring Bridge Bank
Private Equity (2017): $4.2M, investors not publicly disclosed
Series C (2017): $15M with participation from Healthcare Ventures, Greenspring Global Partners, 1315 Capital, and Montreux Equity Partners
Debt (2020): $1M led by PPP
Debt (2020): $30M supported by K2 HealthVentures
Debt (2021): $1.9M featuring PPP
Key Investors in Colorescience
Healthcare Ventures
HealthCare Ventures is a leading life science venture capital firm investing in pre-clinical or early clinical stage, focused companies with potential to transform patient care.
Greenspring Global Partners
Founded in 2000, Greenspring Associates is a venture capital investment firm that serves as a lifecycle partner for fund managers and entrepreneurs both on a primary and secondary basis across multiple stages, sectors and geographies.
1315 Capital
1315 Capital is a healthcare-focused investment firm that specializes in commercial-stage healthcare companies, including healthcare services, pharma/medtech products, and health and wellness.
What's next for Colorescience?
Following this latest capital injection, Colorescience is well-positioned to accelerate its growth trajectory through expanded product development and deeper penetration into international markets. The company's strategic roadmap likely involves scaling its digital infrastructure to support its direct-to-consumer growth while simultaneously strengthening its professional channel relationships. By maintaining its commitment to clinical validation and high-performance ingredients, Colorescience is poised to capitalize on the increasing consumer demand for medical-grade skincare solutions. Future initiatives will likely focus on operational efficiency and the continued expansion of its proprietary mineral-based technology, ensuring the brand remains at the forefront of the evolving global skincare industry.
See full Colorescience company page
